Naldi L - Search Results

1

Identification of cases and estimate of direct costs of unresectable and advanced cutaneous squamous cell carcinoma: real-world data from a large Italian database.

Ronconi G, Piccinni C, Dondi L, Calabria S, Pedrini A, Esposito I, Ascierto PA, Naldi L, Martini N. Ronconi G, et al. Among authors: naldi l. Br J Dermatol. 2020 Jul;183(1):172-174. doi: 10.1111/bjd.18888. Epub 2020 Feb 25. Br J Dermatol. 2020. PMID: 31972051 No abstract available.

2

Dietary factors and the risk of psoriasis. Results of an Italian case-control study.

Naldi L, Parazzini F, Peli L, Chatenoud L, Cainelli T. Naldi L, et al. Br J Dermatol. 1996 Jan;134(1):101-6. Br J Dermatol. 1996. PMID: 8745893

3

Naldi L, DiLandro A, D'Avanzo B, Parazzini F. Naldi L, et al. J Am Acad Dermatol. 2000 Mar;42(3):446-52. doi: 10.1016/s0190-9622(00)90217-2. J Am Acad Dermatol. 2000. PMID: 10688715

4

Distribution of congenital melanocytic naevi and congenital naevus-like naevi in a survey of 3406 Italian schoolchildren.

Gallus S, Naldi L; Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology. Gallus S, et al. Among authors: naldi l. Br J Dermatol. 2008 Aug;159(2):433-8. doi: 10.1111/j.1365-2133.2008.08656.x. Epub 2008 Jun 28. Br J Dermatol. 2008. PMID: 18547318

5

Melanoma excision: how deep must we go?

Naldi L. Naldi L. Br J Dermatol. 2014 Dec;171(6):1291-2. doi: 10.1111/bjd.13459. Br J Dermatol. 2014. PMID: 25523254 No abstract available.

6

Overweight, diabetes and disease duration influence clinical severity in hidradenitis suppurativa-acne inversa: evidence from the national Italian registry.

Bettoli V, Naldi L, Cazzaniga S, Zauli S, Atzori L, Borghi A, Capezzera R, Caproni M, Cardinali C, De Vita V, Donini M, Fabbrocini G, Gimma A, Pasquinucci S, Patrizi A, Pinna AL, Raone B, Ricci M, Virgili A, Balestri R. Bettoli V, et al. Among authors: naldi l. Br J Dermatol. 2016 Jan;174(1):195-7. doi: 10.1111/bjd.13864. Epub 2015 Nov 8. Br J Dermatol. 2016. PMID: 25913460 No abstract available.

7

Prediction of high total naevus count to estimate melanoma risk. We need more, don't we?

Naldi L, Cazzaniga S. Naldi L, et al. Br J Dermatol. 2016 Feb;174(2):261-2. doi: 10.1111/bjd.14334. Br J Dermatol. 2016. PMID: 26871917 No abstract available.

8

Inequalities in access to biological treatments for psoriasis: results from the Italian Psocare registry.

Naldi L, Cazzaniga S, Di Mercurio M, Grossi E, Addis A; Psocare study centres. Naldi L, et al. Br J Dermatol. 2017 May;176(5):1331-1338. doi: 10.1111/bjd.15234. Epub 2017 Apr 5. Br J Dermatol. 2017. PMID: 27973689 Free article.

9

Biologic treatment for psoriasis and cancer: an increased risk for most cancers could not be ruled out.

Naldi L. Naldi L. Br J Dermatol. 2018 Jan;178(1):19. doi: 10.1111/bjd.16067. Br J Dermatol. 2018. PMID: 29357587 No abstract available.

10

Cumulative exposure to biological therapy and risk of cancer in patients with psoriasis: a meta-analysis of Psonet studies from Israel, Italy, Spain, the U.K. and Republic of Ireland.

Garcia-Doval I, Descalzo MA, Mason KJ, Cohen AD, Ormerod AD, Gómez-García FJ, Cazzaniga S, Feldhamer I, Ali H, Herrera-Acosta E, Griffiths CEM, Stern RS, Naldi L; Psonet Network. Garcia-Doval I, et al. Among authors: naldi l. Br J Dermatol. 2018 Oct;179(4):863-871. doi: 10.1111/bjd.16715. Epub 2018 Jul 24. Br J Dermatol. 2018. PMID: 29723914 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

498 results

Search Page